Inovio Pharmaceuticals, Inc.
July 03, 2025 - by Joey Ramson
$INO, a biotech company that is involved in DNA medicines for HPV-related diseases, cancer, and infectious diseases, has priced a $25 million public offering of common stock and warrants, resulting in a gap-down and new 52-week lows.
